118 related articles for article (PubMed ID: 31101169)
1. Oxidative DNA Damage Is Increased in Living Kidney Donors.
Karahan M; Yildirim M; Kucuk HF; Turunc V; Demir H; Salturk C; Yavuz A; Demir T; Ari E
Transplant Proc; 2019 May; 51(4):1049-1053. PubMed ID: 31101169
[TBL] [Abstract][Full Text] [Related]
2. Increased Oxidative Stress in Living Kidney Donors: Correlation of Renal Functions With Antioxidant Capacity.
Yildirim M; Karahan M; Kucuk HF; Demir T; Demir H; Turan H; Yavuz A; Ari E
Transplant Proc; 2017 Apr; 49(3):407-410. PubMed ID: 28340801
[TBL] [Abstract][Full Text] [Related]
3. Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage.
Kaya Y; Ari E; Demir H; Soylemez N; Cebi A; Alp H; Bakan E; Gecit I; Asicioglu E; Beytur A
Nephrol Dial Transplant; 2012 Mar; 27(3):1164-9. PubMed ID: 21821836
[TBL] [Abstract][Full Text] [Related]
4. Single-Center Long-Term Follow-Up of Kidney Donors in Argentina (Hospital Italiano de Buenos Aires).
Mombelli CA; Giordani MC; Imperiali NC; Groppa SR; Villamil Cortez SK; Schreck CM; Rosa-Diez GJ
Transplant Proc; 2018 Mar; 50(2):418-422. PubMed ID: 29579818
[TBL] [Abstract][Full Text] [Related]
5. Medical risk analysis of renal transplant donors.
Berber I; Tellioglu G; Kilicoglu G; Ozgezer T; Canbakan M; Gulle S; Yigit B; Titiz I
Transplant Proc; 2008; 40(1):117-9. PubMed ID: 18261562
[TBL] [Abstract][Full Text] [Related]
6. Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.
Massie AB; Holscher CM; Henderson ML; Fahmy LM; Thomas AG; Al Ammary F; Getsin SN; Snyder JJ; Lentine KL; Garg AX; Segev DL
JAMA Surg; 2020 Mar; 155(3):e195472. PubMed ID: 31968070
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Follow-up Care System of Living Kidney Donors in Monitoring of Residual Kidney Function.
Kwapisz M; Kieszek R; Jędrzejko K; Bieniasz M; Gozdowska J; Kwiatkowski A
Transplant Proc; 2018; 50(6):1590-1596. PubMed ID: 30056866
[TBL] [Abstract][Full Text] [Related]
8. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
[TBL] [Abstract][Full Text] [Related]
9. Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients.
Ari E; Kaya Y; Demir H; Cebi A; Alp HH; Bakan E; Odabasi D; Keskin S
Hemodial Int; 2011 Oct; 15(4):453-9. PubMed ID: 22111813
[TBL] [Abstract][Full Text] [Related]
10. Increase in 24-Hour Protein Excretion Immediately After Donation Is Associated With Decreased Functional Recovery in Living Kidney Donors.
Na JC; Yoon MG; Lee HH; Yoon YE; Kim DG; Huh KH; Kim YS; Han WK
Transplant Proc; 2019 Oct; 51(8):2543-2548. PubMed ID: 31473006
[TBL] [Abstract][Full Text] [Related]
11. Computed Tomography Volumetry in Preoperative Living Kidney Donor Assessment for Prediction of Split Renal Function.
Wahba R; Franke M; Hellmich M; Kleinert R; Cingöz T; Schmidt MC; Stippel DL; Bangard C
Transplantation; 2016 Jun; 100(6):1270-7. PubMed ID: 26356175
[TBL] [Abstract][Full Text] [Related]
12. Effects of preexistent hypertension on blood pressure and residual renal function after donor nephrectomy.
Tent H; Sanders JS; Rook M; Hofker HS; Ploeg RJ; Navis G; van der Heide JJ
Transplantation; 2012 Feb; 93(4):412-7. PubMed ID: 22217533
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of living kidney donors: a longitudinal study.
El-Agroudy AE; Sabry AA; Wafa EW; Neamatalla AH; Ismail AM; Mohsen T; Khalil AA; Shokeir AA; Ghoneim MA
BJU Int; 2007 Dec; 100(6):1351-5. PubMed ID: 17941927
[TBL] [Abstract][Full Text] [Related]
14. Cinacalcet may improve oxidative DNA damage in maintenance hemodialysis patients: an observational study.
Ari E; Kaya Y; Demir H; Asicioglu E; Eren Z; Celik E; Arikan H
Int Urol Nephrol; 2014 Sep; 46(9):1843-9. PubMed ID: 24811568
[TBL] [Abstract][Full Text] [Related]
15. Five-year follow-up after live donor nephrectomy - cross-sectional and longitudinal analysis of a prospective cohort within the era of extended donor eligibility criteria.
Janki S; Dols LF; Timman R; Mulder EE; Dooper IM; van de Wetering J; IJzermans JN
Transpl Int; 2017 Mar; 30(3):266-276. PubMed ID: 27717017
[TBL] [Abstract][Full Text] [Related]
16. Implications of excess weight on kidney donation: Long-term consequences of donor nephrectomy in obese donors.
Serrano OK; Sengupta B; Bangdiwala A; Vock DM; Dunn TB; Finger EB; Pruett TL; Matas AJ; Kandaswamy R
Surgery; 2018 Nov; 164(5):1071-1076. PubMed ID: 30149934
[TBL] [Abstract][Full Text] [Related]
17. Post-nephrectomy development of renal function in living kidney donors: a cross-sectional retrospective study.
Fehrman-Ekholm I; Kvarnström N; Söfteland JM; Lennerling A; Rizell M; Odén A; Simonsson T
Nephrol Dial Transplant; 2011 Jul; 26(7):2377-81. PubMed ID: 21459783
[TBL] [Abstract][Full Text] [Related]
18. Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients.
Tarng DC; Wen Chen T; Huang TP; Chen CL; Liu TY; Wei YH
J Am Soc Nephrol; 2002 May; 13(5):1321-30. PubMed ID: 11961020
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of renal function in a specific population of living kidney donors.
de Souza Rodrigues T; Amorim de Albuquerque AL; de Oliveira Cosme FA; de Oliveira JAMG; Magalhães I; Teles F; Pedrosa AF
J Ren Care; 2017 Jun; 43(2):114-120. PubMed ID: 28233463
[TBL] [Abstract][Full Text] [Related]
20. A prospective controlled study of living kidney donors: three-year follow-up.
Kasiske BL; Anderson-Haag T; Israni AK; Kalil RS; Kimmel PL; Kraus ES; Kumar R; Posselt AA; Pesavento TE; Rabb H; Steffes MW; Snyder JJ; Weir MR
Am J Kidney Dis; 2015 Jul; 66(1):114-24. PubMed ID: 25795073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
